Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...
AI chipmaker Nvidia ( NVDA) and pharmaceutical giant Eli Lilly ( LLY) on Monday announced that the two companies will jointly ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue and net income.
Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.
Barchart on MSN
What to expect from Eli Lilly’s Q4 2025 earnings report
Boasting a market cap of $1 trillion, Eli Lilly and Company (LLY) is a major global research-based pharmaceutical company ...
Eli Lilly stock prepares €15B Abivax acquisition as tirzepatide revenue hits $24.8B. Orforglipron oral weight loss drug ...
24/7 Wall St. on MSN
Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future
One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...
Nvidia and Eli Lilly are partnering to launch a co-innovation lab to use Nvidia's artificial-intelligence and robotics expertise for drug discovery.
Eli Lilly has doubled its investment in its new Concord manufacturing facility from $1 billion to $2 billion since construction began in 2022, the company confirmed. The pharmaceutical giant hosted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results